Articles related to Infectious Diseases

U.S. News expanded its 2026-2027 hospital rankings with new regional specialty evaluations in cancer and cardiovascular care while increasing recognition for regional hospitals. Rankings continued to emphasize risk-adjusted mortality, preventable complications, patient experience, and objective outcomes measures.

Fluvoxamine reduced fatigue and improved quality-of-life measures in adults with long COVID in a randomized placebo-controlled trial. The findings provide evidence for a potential therapy, although further research is needed to define optimal patient selection and treatment strategies.

More than 4,100 laboratory-confirmed cyclospora infections have been reported across 41 states during a larger-than-usual US outbreak. Investigators continue to search for the source, and no food product has been definitively confirmed as responsible.

A nationwide surveillance study identified widespread community reservoirs of multidrug-resistant Klebsiella pneumoniae associated with recurrent urinary tract infections and antibiotic resistance.

Health officials are monitoring a multistate increase in Cyclospora infections associated with prolonged diarrheal illness and suspected foodborne exposure.

A randomized noninferiority trial found that oral fosfomycin matched continued intravenous therapy in stabilized patients with ESBL complicated UTIs after 3 to 7 days of initial IV treatment.